Hata, Hironobu
Shimomura, Satoshi
Imamachi, Kenji
Sato, Jun
Asaka, Takuya
Hirata, Kenji
Funayama, Kyousuke
Mori, Yoichi
Matsuzaka, Masashi
Nambu, Toshikazu
Kitagawa, Yoshimasa
Article History
Received: 21 May 2023
Accepted: 23 February 2024
First Online: 5 March 2024
Declarations
:
: This cross-sectional study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Hokkaido Cancer Center Hospital Ethics Review Board (registration number: 02–31). This study was conducted within the scope of routine clinical practice and was neither invasive nor burdensome to patients, as the uptake time did not exceed the conventional 3 h at our facility. Oral informed consent was obtained from all participants, and consent acquisition was recorded in the patients’ medical records, which was approved by the Hokkaido Cancer Center Hospital Ethics Review Board.
: Not applicable.
: The authors declare that they have no competing interests.